Brainmab's ultimate goal is to minimize the effort of information transfer until there's no effort. This goal can be extended to store every aspect of a person's conscious mind up in a blockchain network free to access any other's if they prefer.
Associate Professor, Cognitive Neuro-psychiatry Researcher, PhD in Biophysics
CEO & Founder
Ali Oztas is the founder and CEO of Brainmab, a global ecosystem of brain blockchain interfaces. Mr.Oztas has over 6 years experience in IT Development&Reseach. He is currently working on improving his revolutionary Blockchain research.
Yıldırım Bakır is a lobbyist, economist and founder of A Plus S.A Luxembourg. He holds a BBA from Brusselles University. Mr. Bakır has worked in SWIFT Banking Industry, Coca-Cola Co. and many more. Currently he works as CEO in his own company A Plus S.A.
2010 graduated from Shandong Agricultural University, more than 8 years of experience in streaming media development, before working in Letv, Cheetah mobile, now engaged in big data development at Baidu.
Qin Shenglin, graduated from the Computer Institute of Jilin University, is engaging in automatic driving and huge data related work in Baidu’s Autonomous Driving Unit.
8 years of programming experience, has done many large-scale Internet projects, continuous entrepreneurs. The whole stack engineer has practical experience in product design, promotion and operation as well as team work.
Toprak Ozturk is a medical student at the University of Kocaeli with 6 years of programming experience. He is an energetic solutions-seeker with a great entrepreneurial mindset. Mr. Ozturk is specialized in neuroscience, Brain- Computer Interface technologies, and bioinformatics.
Shandong university MBA, serial entrepreneur, 7 years mobile Internet experience. The design and core research and development work of many mobile Internet products, such as mobile life. Founder of MADA tech.
Erdal Can Alkoclar
Erdal Can Alkoclar is a Turkish inventor, scientist and investor. Alkoclar is the co-founder and running president of Yesilalkoclar R&D company. He is the sole inventor of 143 applied and 282 pending patents; 44 of them being in current PCT protection. Alkoclar also is the rights holder and applicant of the largest amount of pharmaceutical ingredient patents as sole individual in Turkey. Alkoclar has won a 4th price which is given by Turkish Patent Institute for having the 4th largest number of applied patents in 2014.
Healthcare IT and Life-Sciences industry veteran with a career span including IBM Watson Health, Intel Corp Digital Health Group, World Health Organization and Medicare Australia. He advises blockchain and AI focused startups through Bloxperiment, a social experimentation company that measures the social and economic impact of blockchain and AI technologies on the society’s long-term welfare.
Ali Osman Cibikdiken
Ali Osman Cibikdiken is an assistant professor at Department of Computer Engineering, Necmettin Erbakan University, Turkey. He received his Master’s in Applied Mathematics in 2002 and his PhD in Applied Mathematics from Selcuk University in 2008. His current research interests include Machine Learning, Cloud Computing, Big Data, and Blockchain. He also manages Advanced Computation and Data Analytics Laboratory.
He is an associate professor of Biophysics in Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey. He received his BSc in Physics from Middle East Technical University, and PhD in Biophysics from Hacettepe University Medical Faculty. He worked in CerCo (Brain and Cognition Research Center), a top-rank CNRS Lab in Toulouse/France between years 2010-2012 as postdoctoral research scientist on Brain Oscillations’ relations with attention and perception. Among his current research interests are Cognitive neuro-psychiatry, brain electrophysiology, connectivity and mapping, Real-time computation and Embedded Systems, High-performance computing, Machine Learning, and Brain-Computer interfaces. He is a keen C/C++ developer and also the PI of the Computational Cognitive Neuroscience Laboratory at Konya Necmettin Erbakan University Biophysics Department.